These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 3045106

  • 1. Pharmacological effects of serotonin reuptake inhibitors.
    Leonard BE.
    J Clin Psychiatry; 1988 Aug; 49 Suppl():12-7. PubMed ID: 3045106
    [Abstract] [Full Text] [Related]

  • 2. Pharmacologic properties of serotonergic agents and antidepressant drugs.
    Fuller RW.
    J Clin Psychiatry; 1987 Mar; 48 Suppl():5-11. PubMed ID: 3493240
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050.
    Shaw AM, Boules M, Zhang Y, Williams K, Robinson J, Carlier PR, Richelson E.
    Eur J Pharmacol; 2007 Jan 19; 555(1):30-6. PubMed ID: 17109850
    [Abstract] [Full Text] [Related]

  • 10. [Biochemical aspects of depression (author's transl)].
    Duchemin AM.
    Sem Hop; 2007 Jan 19; 57(15-16):745-50. PubMed ID: 6269184
    [Abstract] [Full Text] [Related]

  • 11. Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule.
    O'Donnell JM, Marek GJ, Seiden LS.
    Neurosci Biobehav Rev; 2005 Jan 19; 29(4-5):785-98. PubMed ID: 15893376
    [Abstract] [Full Text] [Related]

  • 12. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM.
    Neuropharmacology; 2008 Nov 19; 55(6):1006-14. PubMed ID: 18761360
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Molecular and cellular mechanisms of antidepressant drugs.
    Owens MJ.
    Depress Anxiety; 2008 Nov 19; 4(4):153-9. PubMed ID: 9166647
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Some effects of mianserine (ORG GB 94) on amine metabolism in the rat brain.
    Leonard BE.
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Mar 19; 10(2):92-5. PubMed ID: 616924
    [Abstract] [Full Text] [Related]

  • 17. A common uptake system for serotonin and dopamine in human platelets.
    Omenn GS, Smith LT.
    J Clin Invest; 1978 Aug 19; 62(2):235-40. PubMed ID: 670392
    [Abstract] [Full Text] [Related]

  • 18. Studies on the biochemical mode of action of EGYT-475, a new antidepressant.
    Tekes K, Tóthfalusi L, Malomvölgyi B, Hermán F, Magyar K.
    Pol J Pharmacol Pharm; 1987 Aug 19; 39(2):203-11. PubMed ID: 2448760
    [Abstract] [Full Text] [Related]

  • 19. 6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.
    Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, Marchioro C, Merlo-Pich E, Negri M, Oliosi B, Ratti E, Read KD, Roscic M, Sartori I, Spada S, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L, Di Fabio R.
    J Med Chem; 2010 Jul 08; 53(13):4989-5001. PubMed ID: 20527970
    [Abstract] [Full Text] [Related]

  • 20. The contribution of drug research to investigating the nature of endogenous depression.
    Carlsson A.
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan 08; 9(1):2-10. PubMed ID: 10584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.